Trial intelligence / Profile preview

Oxytocin and Trait Anxiety on Defensive Networks

NCT02682888Completed

Sponsor
University of Electronic Science and Technology of China
Start
Dec 2015
Primary completion
Aug 2021
Countries
1
01

Overview

Randomised trial of oxytocin nasal spray in anxiety disorder (4 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoint: Resting state functional connectivity changes in the defensive network at 1 day. Started Dec 2015; status: completed.

02

Drugs

oxytocin nasal spray
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on NCT02682888.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02682888.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call